Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EGFR | P00533 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL6698331 | 0.89 | — | — | |
| SCHEMBL9253 | 0.86 | — | — | |
| Hydrochloric Acid SCHEMBL9158754 | 0.83 | — | — | |
| Ammonia Solution, Strong SCHEMBL28082286 | 0.83 | — | — | |
| Ammonia Solution, Strong SCHEMBL1793738 | 0.83 | EPHX1 (0.40) | EPHX1POLBMEN1KMT2AEGFR | |
| Carbamic Acid SCHEMBL8964476 | 0.78 | ACHE (0.41) | EPHX1POLBMEN1KMT2AEGFR | |
| Tert-Butylamine SCHEMBL910388 | 0.78 | EPHX1 (0.37) | EPHX1POLBMEN1KMT2AEGFR | |
| Ethylenediamine SCHEMBL6467532 | 0.74 | KDM4E (0.36) | EPHX1POLBMEN1KMT2AEGFR | |
| SCHEMBL766017 | 0.74 | — | — | |
| Piperazine SCHEMBL7588405 | 0.74 | EGFR (0.35) | EPHX1POLBMEN1KMT2AEGFR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111393325-A | Novel method for synthesizing chlorocyanomethane | 宁波海曙琼杰化工技术研发工作室 | 2020-07-10 | — | — | CN | disclosed |